Effect of Cholestyramine on Tissue Pools of Cholesterol a Preliminary Report 1

B. Kudchodkar,H. Sodhi,L. Horlick,D. Nazir
DOI: https://doi.org/10.3181/00379727-148-38546
1975-02-01
Abstract:Summary Four Type II Hyperlipopro-teinemic subjects were investigated before and after treatment with cholestyramine. Plasma cholesterol was significantly reduced (365 ± 23 vs 273 ± 34 mg/100 ml) and tri-glycerides significantly increased (149 ± 55 vs 181 ± 59 mg/100 ml) on cholestyramine treatment. The daily turnover of cholesterol, as determined by the method of Goodman and Noble, was nearly doubled by the treatment (0.813 ± 0.11 vs 1.595 ± 0.176 g). Although previous workers have already suggested that cholestyramine does not decrease tissue cholesterol pools, we observed a significant increase in tissue pools in each of the three subjects given cholestyramine alone (10.1 ± 1.4 vs 16.2 ± 6.9 g) for Pool A—excluding plasma; and 27.2 ± 4.6 vs 43.7 ± 6.4 g for Pool B). Treatment for the fourth subject consisted of a combination of cholestyramine and clofibrate. This combination appeared to prevent increases in the size of Pool B and in the size and production rate of Pool A. These preliminary observations suggest that the hypocholesterolemic effect of cholestyramine may be enhanced and its effects on tissue cholesterol prevented by giving it in combination with other agents such as clofibrate.
What problem does this paper attempt to address?